2023 Fall Clinical Virtual Grand Rounds

2023 Virtual Grand Rounds Session 5: March 29, 2023 - Highlights from the AAD

About

Fall Clinical Virtual Grand Rounds consists of regularly scheduled CME sessions on a variety of dermatological diseases and tools, delivered by the top experts in dermatology.

Please join us for this week's session:
Wednesday, March 29, 2023 
8 PM ET/ 5 PM PT

Highlights from the AAD

Part I: Highlights from the AAD 2023 on Inflammatory Skin Diseases: Atopic dermatitis, Alopecia, Acne and Rosacea, Psoriasis and More

Part II: Highlights from the AAD 2023 on Pediatric dermatology, Skin Cancers, and Aesthetic Dermatology

 

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

March 29, 2023

Expiration Date:

March 29, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Apply the latest evidence-based guidelines and data to management of patients with a range of dermatologic conditions

  • Evaluate findings from recent clinical trials to identify appropriate adjustments to current treatment and management strategies

  • Recognize the benefits of newly studied treatments

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
April
April Armstrong, MD, MPH

Chief, Division of Dermatology
Professor of Dermatology
Associate Dean of Clinical Research
Keck School of Medicine of USC
Los Angeles, CA

Brett
Brett King, MD, PhD

Associate Professor of Dermatology
Yale School of Medicine
New Haven, CT

Peter
Peter Lio, MD

Clinical Assistant Professor of Dermatology Pediatrics 
Northwestern University Feinberg School of Medicine
Chicago, IL

Minnelly
Minnelly Luu, MD

Chief, Pediatric Dermatology
Children's Hospital Los Angeles
Associate Professor of Dermatology
USC Keck School of Medicine
Los Angeles, CA

Mark
Mark Nestor, MD, PhD

Director of Center for Clinical and Cosmetic Research
Voluntary Professor, Dermatology
University of Miami, Miller School of Medicine
Miami, FL

Linda
Linda Stein Gold, MD

Director Clinical Research 
Henry Ford Health System 
Detroit, MI

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

April W. Armstrong, MD, MPH

Grant/Research Support: BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer, AbbVie, ASLAN, BI, EPI, Incyte, Janssen 

Consultant: Lilly, Novartis, Ortho, SUN, Dermavant, Dermira, Sanofi Regeneron, Pfizer, Parexel 

Brett A. King, MD, PhD

Consultant: Abbvie, AltruBio Inc, Almirall, AnaptysBio, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Meyers Squibb, Concert Pharmaceuticals Inc, Equillium, Horizon Therapeutics, Eli Lilly and Company, Incyte Corp, Janssen Pharmaceuticals, LEO Pharma, Otsuka/Visterra Inc, Pfizer Inc, Regeneron, Sanofi Genzyme, TWi Biotechnology Inc, and Viela Bio

Speakers’ Bureau or Honoraria: Abbvie, Eli Lilly and Company, Incyte, Pfizer Inc, Regeneron and Sanofi Genzyme

Other Financial Benefit: Clinical trial investigator for AnaptysBio, Arena Pharmaceuticals, Concert Pharmaceuticals Inc, Eli Lilly and Company, NIH, Pfizer Inc.

Peter A. Lio, MD

has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.

Minnelly Luu, MD

has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.

Mark S. Nestor, MD, PhD

Grant/Research Support: CROMA Pharma, Galderma, Merz

Consultant: CROMA Pharma, Revian, Sensus

Speakers’ Bureau or Honoraria: Allergan, AMP, Galderma, Hugel, Sensus

Linda F. Stein Gold, MD

Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie

Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.